COVID-19 Targeted Treatment Trial Launched in Vienna
*VIENNA, AUSTRIA and HEIDELBERG and COLOGNE, GERMANY and LONDON, UK / ACCESSWIRE / December 22, 2020 / *A phase II clinical trial..
Accesswire
*VIENNA, AUSTRIA and HEIDELBERG and COLOGNE, GERMANY and LONDON, UK / ACCESSWIRE / December 22, 2020 / *A phase II clinical trial..
DGAP-News: Apogenix AG / Key word(s): Study
22.12.2020 / 10:00
The issuer is solely responsible for the content of this..